麻豆社

Dr. Mina Farag is a gastrointestinal and liver pathologist, double board certified by the Royal College of Physicians & Surgeons of Canada and the American Board of Pathology. He received his MD degree from Alexandria University, followed by a Master of Science degree and two postdoctoral research fellowships at the Toronto Centre for Liver Diseases, University of Toronto, where his work centered on novel hepatitis B viral biomarkers.

After completing his diagnostic and molecular pathology residency at 麻豆社, Dr. Farag pursued a gastrointestinal and hepatopancreatobiliary pathology fellowship at the University of Chicago under the direction of Dr. John Hart and Dr. Namrata Setia. His main academic interests include liver diseases including viral hepatitis and steatotic liver disease, as well as gastrointestinal oncology and translational biomarker development.

Dr. Farag has authored or co鈥慳uthored more than 30 peer鈥憆eviewed publications and has received multiple awards from the Gastrointestinal Pathology Society (GIPS), as well as several young investigator and early career awards, including the American Association for the Study of Liver Diseases (AASLD) and EASL Young Investigator Awards. During his training, he served as resident chair for the Canadian Association of Pathologists (CAP鈥慉CP) and led Liver Fellow Network initiatives through the AASLD.